Skyward Specialty Insurance (SKWD): Buy, Sell, or Hold Post Q1 Earnings?

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

SKWD Cover Image

Skyward Specialty Insurance’s 25.4% return over the past six months has outpaced the S&P 500 by 17.2%, and its stock price has climbed to $58.31 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

Following the strength, is SKWD a buy right now? Or is the market overestimating its value? Find out in our full research report, it’s free.

Why Is Skyward Specialty Insurance a Good Business?

Founded in 2006 to serve markets where standard insurance coverage falls short, Skyward Specialty Insurance (NASDAQ: SKWD) provides customized commercial property, casualty, and health insurance solutions for underserved or specialized market niches.

1. Net Premiums Earned Skyrocket, Fueling Growth Opportunities

Net premiums earned are net of what’s paid to reinsurers (insurance for insurance companies), which are used by insurers to protect themselves from large losses.

Skyward Specialty Insurance’s net premiums earned has grown at a 27.6% annualized rate over the last two years, much better than the broader insurance industry and in line with its total revenue.

Skyward Specialty Insurance Trailing 12-Month Net Premiums Earned

2. Projected Revenue Growth Is Remarkable

Forecasted revenues by Wall Street analysts signal a company’s potential. Predictions may not always be accurate, but accelerating growth typically boosts valuation multiples and stock prices while slowing growth does the opposite, though some deceleration is natural as businesses become larger.

Over the next 12 months, sell-side analysts expect Skyward Specialty Insurance’s revenue to rise by 25.2%. While this projection is slightly below its 27.6% annualized growth rate for the past two years, it is eye-popping and indicates the market is forecasting success for its products and services.

3. Growing BVPS Reflects Strong Asset Base

In the insurance industry, book value per share (BVPS) provides a clear picture of shareholder value, as it represents the total equity backing a company’s insurance operations and growth initiatives.

Although Skyward Specialty Insurance’s BVPS increased by a meager 1.5% annually over the last four years, the good news is that its growth has recently accelerated as BVPS grew at an incredible 26% annual clip over the past two years (from $17.31 to $27.50 per share).

Skyward Specialty Insurance Quarterly Book Value per Share

Final Judgment

These are just a few reasons Skyward Specialty Insurance is a high-quality business worth owning, and with its shares beating the market recently, the stock trades at 2× forward P/B (or $58.31 per share). Is now the time to initiate a position? See for yourself in our comprehensive research report, it’s free.

Stocks We Like Even More Than Skyward Specialty Insurance

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  254.96
+7.47 (3.02%)
AAPL  327.50
+12.64 (4.01%)
AMD  529.14
-18.99 (-3.46%)
BAC  61.59
+0.97 (1.60%)
GOOG  370.21
+12.88 (3.60%)
META  681.31
+20.27 (3.07%)
MSFT  395.63
+10.70 (2.78%)
NVDA  212.50
+0.70 (0.33%)
ORCL  132.49
+4.55 (3.56%)
TSLA  394.46
-1.72 (-0.43%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.